高级别胶质瘤并非未接受放射治疗的2型神经纤维瘤病患者的特征
该研究通过前瞻性数据库回顾1253例2型神经纤维瘤病(NF2)患者,其中1009例末次随访时存活,旨在明确NF2相关胶质瘤中是否包含恶性胶质瘤(WHO III级和IV级)。结果发现仅1例胶质母细胞瘤(GBM,WHO IV级),无WHO III级胶质瘤,该例患者既往曾因前庭神经鞘瘤接受立体定向放射外科治疗。结论认为未接受放射治疗的NF2患者中高级别胶质瘤并非其特征,应将其从诊断标准中排除。
要点
- 1253例NF2患者中仅1例胶质母细胞瘤(WHO IV级),无WHO III级胶质瘤。
- 该例胶质母细胞瘤患者既往曾因前庭神经鞘瘤接受立体定向放射外科治疗。
- 未接受放射治疗的NF2患者中高级别胶质瘤并非其特征,应从诊断标准中排除。
核心结论
- 高级别胶质瘤并非未接受放射治疗的NF2患者的特征,应将其从诊断标准中排除。
研究设计与样本
- 通过前瞻性数据库回顾性分析1253例NF2患者,其中1009例末次随访时存活。
主要发现
- 系列中仅见1例胶质母细胞瘤(GBM,WHO IV级),无WHO III级胶质瘤。
- 该例GBM患者既往曾因前庭神经鞘瘤接受立体定向放射外科治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Manchester criteria for neurofibromatosis type 2 (NF2) include a range of tumors, and gliomas were incorporated in the original description. The gliomas are now widely accepted to be predominantly spinal cord ependymomas. OBJECTIVE: To determine whether these gliomas include any cases of malignant glioma (WHO grade III and IV) through a database review. METHODS: The prospective database consists of 1253 patients with NF2. 1009 are known to be alive at last follow-up. RESULTS: There was a single case of glioblastoma multiforme (GBM; World Health Organization grade IV) in the series and no WHO grade III gliomas. The GBM was in a patient who had previously undergone stereotactic radiosurgery for a vestibular schwannoma. CONCLUSION: High-grade gliomas are not a feature of NF2 in the unirradiated patient and should be excluded from the diagnostic criteria.
引用
- King AT, Rutherford SA, Hammerbeck-Ward C, et al. High-Grade Glioma is not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient. Neurosurgery. 2018. PMID: 28973691. doi:10.1093/neuros/nyx374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。